{"schema_version":"secwatch.filing_event.v1","accession":"0001730430-26-000025","form_type":"8-K","ticker":"KNSA","cik":"0001730430","company_name":"Kiniksa Pharmaceuticals International, plc","filed_at":"2026-05-26T20:55:02+00:00","discovered_at":"2026-05-26T20:56:00.440952+00:00","generated_at":"2026-05-26T20:57:00.130090+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"confidence":"high","headline":"Kiniksa caps Baker Bros. voting power at 49.9% by waiving conversion rights","bullets":["Baker Bros. entities hold 12.78M A1 and 16.06M B1 shares; they waive conversion into A/B shares if ownership exceeds 49.9% voting rights.","Waiver is irrevocable and unconditional; amendment requires at least 75% shareholder approval.","Deed prohibits circumvention; any conversion attempt violating the cap is void ab initio.","Other shareholder rights (voting, dividends, capital return) remain unaffected."],"urls":{"canonical":"https://secwatch.observer/filing/0001730430-26-000025","json":"https://secwatch.observer/filing/0001730430-26-000025.json","markdown":"https://secwatch.observer/filing/0001730430-26-000025.md","text":"https://secwatch.observer/filing/0001730430-26-000025.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1730430/000173043026000025/0001730430-26-000025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1730430/000173043026000025/knsa-20260521x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T20:57:00.130090+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}